LB Pharmaceuticals Inc
LBRX
$23.91
$0.331.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -80.28% | -80.28% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | -72.97% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -- | -- | -80.08% | ||
|
|
|||||
| Total Current Assets | -- | -- | -80.08% | ||
| Net Property, Plant & Equipment | -- | -- | 5,808.96% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -- | -- | -74.08% | ||
|
|
|||||
| Total Accounts Payable | -- | -- | -52.75% | ||
| Total Accrued Expenses | -- | -- | -65.37% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -- | -- | -55.01% | ||
|
|
|||||
| Total Current Liabilities | -- | -- | -55.01% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | 9.07% | ||
| Total Liabilities | -- | -- | -15.17% | ||
|
|
|||||
| Common Stock & APIC | -- | -- | 62.32% | ||
| Retained Earnings | -- | -- | -99.56% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -- | -105.91% | -105.91% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | 0.00% | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | 0.00% | ||
|
|
|||||
| Total Common Equity | -- | -105.91% | -105.91% | ||
| Total Preferred Equity | -- | 0.00% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -- | -83.72% | -83.72% | ||
|
|
|||||